Heterogeneity of Treatment Effects of Preoperative Embolization in Patients With Brain Arteriovenous Malformations
MCML Authors
Abstract
Abstract
Background/Introduction: Preoperative embolization is widely used as an adjunct to microsurgical resection of brain arteriovenous malformations (AVMs). While a recent meta-analysis found no significant difference in functional outcomes, subgroup studies and clinical experience suggest that the treatment effect of preoperative embolization may vary across different patients.<br>Objective/Purpose: To analyze the treatment effect heterogeneity of preoperative embolization in patients with AVMs and identify subgroups who benefit from preoperative embolization.<br>Methods/Case Description: A total of 487 patients from the Multicenter International Study for Treatment of Brain AVMs consortium were included. We developed a causal forest model to estimate individualized treatment effects (ITEs) in patients who underwent preoperative embolization (n=230) compared to microsurgery alone (n=257). The ITE was defined as the difference in probability of favorable outcome (modified Rankin Scale (mRS ≤ 2) at last follow-up) between the combined treatment group and the microsurgery group.<br>Results/Findings: There was a substantial heterogeneity in ITEs, ranging between −38% and +31%. The average treatment effect was −1% (95% confidence interval: −7 to +5%). A total of 41.5% of patients had a predicted positive ITE, and 11.5% had an ITE > 10%. Our treatment rule targeting the top 30% of patients by predicted ITE improved favorable outcome rates from 83.4% to 90.1% (p=0.04). SHAP analysis identified several factors associated with treatment benefit, including higher age, larger nidus volume, higher preoperative mRS, multiple feeders and diffuse morphology.<br>Discussion/Conclusions/Learning: Points Our study demonstrated a substantial heterogeneity in the treatment effect of preoperative embolization, despite the absence of an average treatment effect on a population level. Our findings underscore the role of preoperative embolization in selected patients with larger, higher-flow AVMs.
article CHF+26
Journal of NeuroInterventional Surgery
18.A32-A33. Sep. 2026.Authors
O. Ciobanu-Caraus • P. Heesen • S. Feuerriegel • N. Adeeb • M. Bendszus • M. A. Möhlenbruch • J.-K. Burkhardt • S. Kandregula • V. M. SrinivasanLinks
DOIResearch Area
BibTeXKey: CHF+26